Mumbai gets second civic-run centre for transplant of bone marrow

MUMBAI: In a few weeks, a second civic-run centre will start performing bone marrow transplants in the city. The eight-bed centre housed inside Borivli’s new super-speciality hospital will offer the life-saving treatment at half the cost of what a private centre charges.

Thousands of children with blood cancers and disorders, such as leukaemia, lymphoma, sickle cell anaemia and thalassemia, depend on a bone marrow transplant to save their lives. Besides finding a match, cost often becomes a constraint for families to avail of the treatment. The centre that became functional since last year will act as a specialised facility for blood disorders, particularly catering to paediatric patients.

“The surgery will be done for Rs 12 lakh. Trusts and NGOs will help us to raise the treatment cost,” said Dr Mamata Manglani, head of the facility. The first civic-run facility that was started at Sion Hospital in 2015 has performed 19 transplants so far. Tata Trust that played a big role in financing the Sion centre has also funded the Borivli centre. “Since the focus of this hospital is not so much on treating general ailments, it won’t be overcrowded,” Manglani said. tnn

  • Related Posts

    Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

    Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

    On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

    Chennai hosts 3 Day International Conference CAHOCON on Patient Safety in Hospitals starting April 10 New Delhi:  Patient safety in hospitals is a global concern, more so in India. It…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid